What's Happening?
The Texas Rangers have signed right-handed relief pitcher Declan Cronin to a two-year minor league contract. Cronin, who underwent Tommy John surgery in September, is expected to miss the entire 2026 MLB season. The Rangers' decision to sign Cronin is seen as a strategic move, anticipating his potential contribution in the 2027 season. Cronin, a 6-foot-4 pitcher, was originally a 36th-round pick by the Chicago White Sox and has played for the Miami Marlins, where he posted a 4.35 ERA in 2024. The signing is considered low-risk for the Rangers, providing Cronin with organizational support during his rehabilitation.
Why It's Important?
This signing reflects the Rangers' long-term strategy to bolster their bullpen by investing in a player with potential upside post-recovery. For Cronin, the contract offers stability and support during his recovery period, which is crucial for athletes undergoing significant surgeries like Tommy John. The move also highlights the Rangers' willingness to take calculated risks on players who may not contribute immediately but could offer significant value in the future. This approach could influence other MLB teams to adopt similar strategies, focusing on long-term gains over immediate results.
What's Next?
Cronin will focus on his rehabilitation process with the support of the Rangers' medical and training staff. The team will likely monitor his progress closely, with the aim of integrating him into their roster for the 2027 season. The Rangers' management may continue to explore similar low-risk signings to strengthen their future lineup. Meanwhile, Cronin's recovery and potential return to form will be watched by both the team and fans, as successful rehabilitation could set a precedent for other players in similar situations.
